Veritas In Silico Inc. (TYO:130A)
264.00
+39.00 (17.33%)
Nov 18, 2026, 11:30 AM JST
Veritas In Silico Market Cap
Veritas In Silico has a market cap or net worth of 1.71 billion as of November 17, 2026. It is the 40,824th most valuable company in the world and the 3,724th biggest in Japan. Its market cap has decreased by 49.33% in one year.
Market Cap
1.71B
Enterprise Value
282.29M
Revenue
84.42M
Global Rank
Country Rank
#3,724 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 8, 2024, Veritas In Silico's market cap has decreased from 15.76B to 1.71B, a decrease of -89.13%. That is a compound annual growth rate of -55.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 1.71B | -45.00% |
| Dec 30, 2025 | 3.11B | -45.58% |
| Dec 30, 2024 | 5.72B | -63.69% |
| Feb 8, 2024 | 15.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chordia Therapeutics | 3.33B |
| Modalis Therapeutics | 3.18B |
| Ribomic | 3.18B |
| Kohjin Bio | 3.14B |
| PRISM BioLab Co.,LTD | 3.10B |
| Transgenic Group | 3.03B |
| Human Metabolome Technologies | 3.03B |
| D. Western Therapeutics Institute | 2.76B |